Form 4: Plexus Corp Director Karen Rapp Sells 500 Shares Under 10b5-1 Plan

Plexus Corp director Karen Rapp sold 500 shares of common stock at $162.86 per share on November 29, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Director Karen Rapp sold 500 shares of Plexus Corp common stock on November 29, 2024.
• The sale was executed at a price of $162.86 per share.
• This transaction was conducted under a Rule 10b5-1 trading plan adopted on February 28, 2024.
• Following the transaction, Ms. Rapp directly owns 8,386 shares of Plexus Corp stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing for an insider stock sale under a pre-arranged plan, indicating a neutral sentiment.

Risks

• Sales by insiders can sometimes be perceived negatively by the market, potentially impacting the stock price.

Industry Context

Insider trading activity is a common occurrence in publicly traded companies, and Form 4 filings are a standard part of regulatory compliance.

Comparison to Industry Standards

• Rule 10b5-1 plans are a common tool used by corporate insiders to manage their stock sales and avoid accusations of insider trading.
• The sale of 500 shares is a relatively small transaction compared to the overall trading volume of Plexus Corp stock.
• Other directors and officers of Plexus Corp may also have similar trading plans in place.

Stakeholder Impact

• The sale of shares by a director may have a minor impact on shareholder sentiment.

Key Dates

Keywords

Plexus Corp, insider trading, Form 4, Karen Rapp, stock sale, Rule 10b5-1, director